Steven C Gilman Akebia Therapeutics, Inc. (AKBA) insider trading activity

Steven C Gilman is of Akebia Therapeutics, Inc.. Currently has a direct ownership of 152,830 shares of AKBA, which is worth approximately $588,395. The most recent transaction as insider was on Jun 10, 2025, when has been sold 35,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 153K

30.48% 3M change

30.48% 12M change

Total Value Held $588,395

STEVEN C GILMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 10 2025	BUY Grant, award, or other acquisition	-	35,700 Added 18.94%	152,830 Common Stock
Jun 06 2024	BUY Grant, award, or other acquisition	-	30,000 Added 20.39%	117,130 Common Stock
Jun 06 2023	BUY Grant, award, or other acquisition	-	30,000 Added 25.61%	87,130 Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	-	13,700 Added 19.34%	57,130 Common Stock
Jun 03 2022	SELL Open market or private sale	$1,644 $0.36 p/Share	4,567 Reduced 9.52%	43,430 Common Stock
Jun 07 2021	SELL Open market or private sale	$15,162 $3.32 p/Share	4,567 Reduced 8.69%	47,997 Common Stock
Jun 02 2021	BUY Grant, award, or other acquisition	-	13,700 Added 20.67%	52,564 Common Stock

Also insider at

SCYX

SCYNEXIS INC Healthcare

VCEL

Vericel Corp Healthcare

CFRX

CONTRAFECT Corp Healthcare

Director

SCG

Steven C Gilman

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Value

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Akebia Therapeutics, Inc.

Track Activities on AKBA

Account